红外/红光治疗仪联合甲钴胺治疗糖尿病周围神经病变的疗效分析  

Efficacy analysis of infrared/red light therapeutic apparatus combined with mecobalamin in the treatment of diabetic peripheral neuropathy

作　　者：安洪春[1] 王建伟[1] AN Hong-chun;WANG Jian-wei(Department of Endocrinology,Jinan First People's Hospital,Jinan 250000,China)

机构地区：[1]济南市第一人民医院内分泌科,250000

出　　处：《中国实用医药》2022年第19期93-96,共4页China Practical Medicine

摘　　要：目的观察红外/红光治疗仪联合甲钴胺治疗糖尿病周围神经病变(DPN)的疗效。方法72例DPN住院患者为研究对象,采用抽签法随机分为治疗组和对照组,每组36例。治疗组采用红外/红光治疗仪联合甲钴胺治疗,对照组采用甲钴胺治疗。比较两组治疗前后神经传导速度、临床疗效及不良反应发生情况。结果治疗组治疗总有效率91.7%高于对照组的69.4%,差异有统计学意义(P<0.05)。治疗后,治疗组正中神经运动传导速度为(55.70±3.55)m/s、尺神经运动传导速度为(59.10±3.80)m/s、腓总神经运动传导速度为(44.77±5.00)m/s、正中神经感觉传导速度为(53.15±5.29)m/s、尺神经感觉传导速度为(44.90±2.91)m/s、腓肠神经感觉传导速度为(47.90±3.60)m/s;对照组正中神经运动传导速度为(46.20±1.90)m/s、尺神经运动传导速度为(48.80±3.90)m/s、腓总神经运动传导速度为(39.52±4.40)m/s、正中神经感觉传导速度为(47.31±4.34)m/s、尺神经感觉传导速度为(42.81±2.90)m/s、腓肠神经感觉传导速度为(44.38±3.50)m/s。治疗后,两组正中神经、尺神经、腓总神经的运动及感觉传导速度均高于本组治疗前,且治疗组高于对照组,差异均有统计学意义(P<0.05)。两组患者均未发生不良反应。结论DPN患者应用红外/红光治疗仪联合甲钴胺治疗具有较好的临床效果,此方法值得在临床推广使用。Objective To observe the efficacy of infrared/red light therapeutic apparatus combined with mecobalamin in the treatment of diabetic peripheral neuropathy(DPN).Methods A total of 72 inpatients with DPN were selected as the research subjects,and were randomly divided into treatment group and control group by drawing lots,with 36 cases in each group.The treatment group was treated with infrared/red light therapeutic apparatus combined with mecobalamin,and the control group was treated with mecobalamin.The nerve conduction velocity before and after treatment,clinical efficacy and occurrence of adverse reactions were compared between the two groups.Results The total effective rate 91.7%of the treatment group was higher than 69.4%of the control group,and the difference was statistically significant(P<0.05).After treatment,the treatment group had a motor conduction velocity of the median nerve of(55.70±3.55)m/s,a motor conduction velocity of the ulnar nerve of(59.10±3.80)m/s,a motor conduction velocity of the common peroneal nerve of(44.77±5.00)m/s,a sensory conduction velocity of median nerve of(53.15±5.29)m/s,a sensory conduction velocity of ulnar nerve of (44.90±2.91) m/s, and a sensory conduction velocity of sural nerve of (47.90±3.60) m/s;the control group had a motor conduction velocity of the median nerve of (46.20±1.90) m/s, a motor conduction velocity of the ulnar nerve of (48.80±3.90) m/s, a motor conduction velocity of the common peroneal nerve of (39.52±4.40) m/s, a sensory conduction velocity of median nerve of (47.31±4.34) m/s, a sensory conduction velocity of ulnar nerve of (42.81±2.90) m/s, and a sensory conduction velocity of sural nerve of (44.38±3.50) m/s. After treatment, the motor and sensory conduction velocities of the median nerve ulnar nerve and common perneal nerve of the two groups were higher than those of this group before treatment, and the treatment group was higher than the control group. All the differences were statistically significant (P<0.05). No adverse reactions occurr

关 键 词：甲钴胺 红外/红光治疗 糖尿病周围神经病变 

分 类 号：R587.2[医药卫生—内分泌]